-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Artiva Biotherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2023 to Q3 2025.
- Artiva Biotherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $1.37M, a 58.6% increase year-over-year.
- Artiva Biotherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $6.96M.
- Artiva Biotherapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $1.91M, a 5.64% decline from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)